Complete Response After High-Dose Methotrexate-Based Chemotherapy as a Major Prognostic Factor for Primary CNS Lymphoma : an Exploratory Analysis of the LNHCP93 Trial of the Groupe d'Etude Des Lymphomes De l'Adulte

---

Autoria(s): Ghesquières H.; Ferlay C.; Bajard A.; Sebban C.; Perol D.; Bosly A.; Casasnovas O.; Reman O.; Coiffier B.; Tilly H.; Morel P.; De Prijck B.; Van den Neste E.; Colin P.; Ketterer N.; Thyss A.; Delannoy A.; Haioun C.; Devidas A.; Biron P.; Blay J.Y.

Data(s)	2009
Identificador	http://serval.unil.ch/?id=serval:BIB_77F115C42976
Idioma(s)	en
Fonte	51st Annual Meeting Of The American Society Of Hematology
Tipo	info:eu-repo/semantics/conferenceObject inproceedings